Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01151527 · ClinicalTrials.gov registry record
Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 269
- Enrollment target
NCT01151527 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 269 participants.
The verdict
NCT01151527 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 269 participants
- Enrollment target
Study Summary
We hypothesize that a peripheral blood biomarker or biological signature (gene or protein expression pattern) of idiopathic interstitial pneumonias (IIPs) will simplify and improve the accuracy of diagnosis of IIP and diagnose individuals at an earlier, more treatable, stage of their disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2010-04 |
| Est. Completion | 2013-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01151527
The ClinicalTrials.gov registry entry for NCT01151527 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 269 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01151527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01151527 about?
NCT01151527 is a clinical study titled "Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias". We hypothesize that a peripheral blood biomarker or biological signature (gene or protein expression pattern) of idiopathic interstitial pneumonias (IIPs) will simplify and improve the accuracy of diagnosis of IIP and diagnose individuals at an earlier, more treatable, stage of their disease.
What is the current status of trial NCT01151527?
This trial is currently terminated. The enrollment target is 269 participants. The study started on 2010-04. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT01151527?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.